Richard W. Paul & Associates’s Eli Lilly LLY Stock Holding History

Richard W. Paul & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Sell	1,267 -6	-0.5%	-$6.08K	0.39%	73
2025 Q4	$1.37M	Sell	1,273 -125	-9%	-$120K	0.45%	58
2025 Q3	$1.07M	Buy	1,398 +173	+14%	+$129K	0.36%	71
2025 Q2	$955K	Buy	1,225 +61	+5%	+$47.4K	0.35%	72
2025 Q1	$961K	Buy	1,164 +1	+0.1%	+$832	0.38%	65
2024 Q4	$898K	Buy	1,163 +136	+13%	+$113K	0.33%	83
2024 Q3	$910K	Sell	1,027 -29	-3%	-$26.1K	0.33%	90
2024 Q2	$956K	Sell	1,056 -38	-3%	-$30.4K	0.37%	70
2024 Q1	$851K	Sell	1,094 -73	-6%	-$52K	0.34%	79
2023 Q4	$680K	Buy	1,167 +257	+28%	+$150K	0.29%	94
2023 Q3	$489K	Sell	910 -339	-27%	-$175K	0.22%	104
2023 Q2	$586K	Buy	1,249 +1	+0.1%	+$419	0.26%	104
2023 Q1	$428K	Buy	1,248 +28	+2%	+$9.44K	0.2%	113
2022 Q4	$446K	Buy	+1,220	New	+$433K	0.22%	103

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Richard W. Paul & Associates's LLY Position: Q1 2026 in Review

Richard W. Paul & Associates reduced its Eli Lilly (LLY) stake by 0.47% in Q1 2026, selling an estimated $6.08K and leaving 1,267 shares worth $1.17M. The position accounts for 0.39% of the portfolio, ranked #73.

Richard W. Paul & Associates first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.37M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Richard W. Paul & Associates held 1,267 shares of Eli Lilly worth $1.17M as of Q1 2026.
Richard W. Paul & Associates sold 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
Eli Lilly made up 0.39% of Richard W. Paul & Associates's portfolio in Q1 2026, its #73 holding.
Richard W. Paul & Associates first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Richard W. Paul & Associates's Eli Lilly position peaked at $1.37M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Richard W. Paul & Associates's 13F filing for Q1 2026, filed 13 May 2026.